Elsevier expands biopharma base

Science and health publishing giant Elsevier has acquired Windhover Information Inc., a leading biotech and pharma business intelligence provider. linkurl:Windhover;http://www.windhover.com/dotcom/home.asp publishes several journals, such as __In Vivo__, __Start-up__ and __The Regulation Policy Market Access Report__, which cover health care marketplace trends, business strategy, industry deal making, and medical start-ups. Acquiring Windhover adds more than 100 journalists to Elsevier's staff

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Science and health publishing giant Elsevier has acquired Windhover Information Inc., a leading biotech and pharma business intelligence provider. linkurl:Windhover;http://www.windhover.com/dotcom/home.asp publishes several journals, such as __In Vivo__, __Start-up__ and __The Regulation Policy Market Access Report__, which cover health care marketplace trends, business strategy, industry deal making, and medical start-ups. Acquiring Windhover adds more than 100 journalists to Elsevier's staff and is expected to strengthen the company's health care industry coverage. "Adding Windhover's expert analysis of the pharmaceutical and medical device industries to our existing regulatory and general business news services and database expands both the depth and breadth of Elsevier's customer offerings," Elsevier Health Sciences CEO, Brian Nairn, said in a company linkurl:statement.;http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/03-10-2008/0004771023&EDATE= This move comes after linkurl:news;http://www.the-scientist.com/blog/display/54358/ last month that Elsevier was selling Reed Business Information, the company's primary business-to-business publisher, which also produces, among others, __New Scientist__ and __Variety__ magazines.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide